We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
+15.81%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$28.7B
AUM Growth
+$4.18B
(+17%)
Cap. Flow
-$12B
Cap. Flow
% of AUM
-41.89%
Top 10 Holdings %
Top 10 Hldgs %
36.41%
Holding
1,665
New
77
Increased
1,003
Reduced
447
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$63.9M |
| 2 |
iShares MBS ETF
MBB
|
+$57.4M |
| 3 |
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
|
+$57.3M |
| 4 |
iShares S&P 100 ETF
OEF
|
+$54M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$31.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$4.13B |
| 2 |
MakeMyTrip
MMYT
|
+$2.41B |
| 3 |
Trip.com Group
TCOM
|
+$770M |
| 4 |
Yum China
YUMC
|
+$508M |
| 5 |
Alibaba
BABA
|
+$477M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.56% |
| 2 | Communication Services | 9.63% |
| 3 | Consumer Discretionary | 9.36% |
| 4 | Healthcare | 6.11% |
| 5 | Financials | 5.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Taysha Gene Therapies
TSHA
$1.92B
| $23.3K | ﹤0.01% |
10,103
+3,731
| +59% | +$8.11K |
|
|
TUYA
1377
Tuya Inc
TUYA
$1.12B
| $23.1K | ﹤0.01% |
+9,997
| New | +$24.3K |
|
1378
Evolus
EOLS
$530M
| $22.9K | ﹤0.01% |
2,491
+407
| +20% | +$4.16K |
|
1379
Relay Therapeutics
RLAY
$4.37B
| $22.9K | ﹤0.01% |
6,623
+1,103
| +20% | +$3.28K |
|
1380
RLJ Lodging Trust
RLJ
$1.67B
| $22.9K | ﹤0.01% |
3,142
-999
| -24% | -$7.2K |
|
1381
Arbutus Biopharma
ABUS
$906M
| $22.9K | ﹤0.01% |
7,399
+1,058
| +17% | +$3.51K |
|
1382
Castle Biosciences
CSTL
$933M
| $22.8K | ﹤0.01% |
1,115
+183
| +20% | +$3.39K |
|
1383
Personalis
PSNL
$1.54B
| $22.4K | ﹤0.01% |
3,412
+459
| +16% | +$2.13K |
|
1384
Teradata
TDC
$2.57B
| $22.3K | ﹤0.01% |
1,000
+224
| +29% | +$4.87K |
|
1385
Iovance Biotherapeutics
IOVA
$2.95B
| $22.2K | ﹤0.01% |
12,900
+1,929
| +18% | +$4.8K |
|
1386
Amylyx Pharmaceuticals
AMLX
$2.5B
| $22.1K | ﹤0.01% |
3,443
+513
| +18% | +$2.5K |
|
|
SAGE
1387
DELISTED
Sage Therapeutics
SAGE
| $22.1K | ﹤0.01% |
2,419
+362
| +18% | +$2.66K |
|
|
KALV
1388
DELISTED
KalVista Pharmaceuticals
KALV
| $21.7K | ﹤0.01% |
1,921
+281
| +17% | +$3.44K |
|
1389
Shift4
FOUR
$3.79B
| $21.7K | ﹤0.01% |
219
-35,831
| -99% | -$3.12M |
|
1390
Xencor
XNCR
$1.71B
| $21.6K | ﹤0.01% |
2,749
+391
| +17% | +$3.51K |
|
1391
ARK Blockchain & Fintech Innovation ETF
ARKF
$782M
| $21.6K | ﹤0.01% |
+430
| New | +$16.9K |
|
1392
Trevi Therapeutics
TRVI
$2.59B
| $21.5K | ﹤0.01% |
3,930
+1,028
| +35% | +$6.4K |
|
1393
Tango Therapeutics
TNGX
$4.32B
| $21.4K | ﹤0.01% |
4,187
+454
| +12% | +$1.12K |
|
1394
Theravance Biopharma
TBPH
$878M
| $21.3K | ﹤0.01% |
1,932
+287
| +17% | +$2.79K |
|
1395
Keros Therapeutics
KROS
$211M
| $20.9K | ﹤0.01% |
1,569
+209
| +15% | +$2.82K |
|
|
CSR
1396
Centerspace
CSR
$939M
| $20.8K | ﹤0.01% |
346
-102
| -23% | -$6.26K |
|
1397
Arvinas
ARVN
$589M
| $20.8K | ﹤0.01% |
2,820
+519
| +23% | +$3.82K |
|
1398
MeiraGTx Holdings
MGTX
$1.17B
| $20.2K | ﹤0.01% |
3,104
+489
| +19% | +$2.89K |
|
1399
Phibro Animal Health
PAHC
$1.38B
| $20.1K | ﹤0.01% |
787
+106
| +16% | +$2.31K |
|
|
AAT
1400
American Assets Trust
AAT
$1.41B
| $20K | ﹤0.01% |
1,013
-303
| -23% | -$5.89K |
|
Similar funds
BC
Mirae Asset Global Investments's Q2 2025 Portfolio in Review
As of Q2 2025, Mirae Asset Global Investments held 1,665 positions worth $28.7B, up 17% from $24.5B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Mirae Asset Global Investments withdrew a net $12B in Q2 2025, closing 86 positions and reducing 447 holdings. Its most notable exit was iShares MSCI ACWI ETF, an estimated $19.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Mirae Asset Global Investments opened a new position in iShares S&P 100 ETF worth $58.9M.
- Mirae Asset Global Investments's largest Q2 2025 buy was iShares S&P 100 ETF: 193,670 shares worth $58.9M.
- Mirae Asset Global Investments added most to State Street SPDR Portfolio S&P 500 ETF in Q2 2025, an estimated $63.9M increase.
- Mirae Asset Global Investments's biggest Q2 2025 reduction was Pinduoduo, cutting an estimated $4.13B.
- Mirae Asset Global Investments fully exited iShares MSCI ACWI ETF in Q2 2025, selling an estimated $19.3M.
- Mirae Asset Global Investments's ten largest holdings make up 36% of its $28.7B portfolio in Q2 2025.
- Mirae Asset Global Investments opened 77 new positions and closed 86 in Q2 2025.
- Mirae Asset Global Investments's portfolio value rose 17% quarter-over-quarter to $28.7B.
Based on Mirae Asset Global Investments's 13F filing for Q2 2025, filed 21 Jul 2025.